Report for Blennow K

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (37)

Title : Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity - Schilling_2023_Acta.Neuropathol.Commun_11_87
Author(s) : Schilling S , Pradhan A , Heesch A , Helbig A , Blennow K , Koch C , Bertgen L , Koo EH , Brinkmalm G , Zetterberg H , Kins S , Eggert S
Ref : Acta Neuropathologica Commun , 11 :87 , 2023
Abstract : Schilling_2023_Acta.Neuropathol.Commun_11_87
ESTHER : Schilling_2023_Acta.Neuropathol.Commun_11_87
PubMedSearch : Schilling_2023_Acta.Neuropathol.Commun_11_87
PubMedID: 37259128

Title : Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer's Disease - Brinkley_2022_Front.Neurosci_16_906539
Author(s) : Brinkley TE , Leng I , Register TC , Neth BJ , Zetterberg H , Blennow K , Craft S
Ref : Front Neurosci , 16 :906539 , 2022
Abstract : Brinkley_2022_Front.Neurosci_16_906539
ESTHER : Brinkley_2022_Front.Neurosci_16_906539
PubMedSearch : Brinkley_2022_Front.Neurosci_16_906539
PubMedID: 35720727

Title : Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry - Camporesi_2022_EBioMedicine_75_103793
Author(s) : Camporesi E , Nilsson J , Vrillon A , Cognat E , Hourregue C , Zetterberg H , Blennow K , Becker B , Brinkmalm A , Paquet C , Brinkmalm G
Ref : EBioMedicine , 75 :103793 , 2022
Abstract : Camporesi_2022_EBioMedicine_75_103793
ESTHER : Camporesi_2022_EBioMedicine_75_103793
PubMedSearch : Camporesi_2022_EBioMedicine_75_103793
PubMedID: 34990894

Title : Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease - Bateman_2022_Alzheimers.Res.Ther_14_178
Author(s) : Bateman RJ , Cummings J , Schobel S , Salloway S , Vellas B , Boada M , Black SE , Blennow K , Fontoura P , Klein G , Assuncao SS , Smith J , Doody RS
Ref : Alzheimers Res Ther , 14 :178 , 2022
Abstract : Bateman_2022_Alzheimers.Res.Ther_14_178
ESTHER : Bateman_2022_Alzheimers.Res.Ther_14_178
PubMedSearch : Bateman_2022_Alzheimers.Res.Ther_14_178
PubMedID: 36447240

Title : Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study - Tofiq_2021_J.Alzheimers.Dis__
Author(s) : Tofiq A , Zetterberg H , Blennow K , Basun H , Cederholm T , Eriksdotter M , Faxen-Irving G , Hjorth E , Jerneren F , Schultzberg M , Wahlund LO , Palmblad J , Freund-Levi Y
Ref : J Alzheimers Dis , : , 2021
Abstract : Tofiq_2021_J.Alzheimers.Dis__
ESTHER : Tofiq_2021_J.Alzheimers.Dis__
PubMedSearch : Tofiq_2021_J.Alzheimers.Dis__
PubMedID: 34420949

Title : Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression - Pomara_2021_J.Affect.Disord_286_275
Author(s) : Pomara N , Bruno D , Plaska CR , Pillai A , Ramos-Cejudo J , Osorio R , Imbimbo BP , Heslegrave A , Zetterberg H , Blennow K
Ref : J Affect Disord , 286 :275 , 2021
Abstract : Pomara_2021_J.Affect.Disord_286_275
ESTHER : Pomara_2021_J.Affect.Disord_286_275
PubMedSearch : Pomara_2021_J.Affect.Disord_286_275
PubMedID: 33756305

Title : Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers - Camporesi_2021_Acta.Neuropathol.Commun_9_19
Author(s) : Camporesi E , Lashley T , Gobom J , Lantero-Rodriguez J , Hansson O , Zetterberg H , Blennow K , Becker B
Ref : Acta Neuropathologica Commun , 9 :19 , 2021
Abstract : Camporesi_2021_Acta.Neuropathol.Commun_9_19
ESTHER : Camporesi_2021_Acta.Neuropathol.Commun_9_19
PubMedSearch : Camporesi_2021_Acta.Neuropathol.Commun_9_19
PubMedID: 33522967

Title : [Alzheimer's disease - the most common cause of dementia] - Bogdanovic_2020_Lakartidningen_117_
Author(s) : Bogdanovic N , Hansson O , Zetterberg H , Basun H , Ingelsson M , Lannfelt L , Blennow K
Ref : Lakartidningen , 117 : , 2020
Abstract : Bogdanovic_2020_Lakartidningen_117_
ESTHER : Bogdanovic_2020_Lakartidningen_117_
PubMedSearch : Bogdanovic_2020_Lakartidningen_117_
PubMedID: 32154904

Title : Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease - Wattmo_2020_BMC.Neurol_20_10
Author(s) : Wattmo C , Blennow K , Hansson O
Ref : BMC Neurol , 20 :10 , 2020
Abstract : Wattmo_2020_BMC.Neurol_20_10
ESTHER : Wattmo_2020_BMC.Neurol_20_10
PubMedSearch : Wattmo_2020_BMC.Neurol_20_10
PubMedID: 31918679

Title : Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid - Bloniecki_2017_J.Alzheimers.Dis_57_387
Author(s) : Bloniecki V , Aarsland D , Blennow K , Cummings J , Falahati F , Winblad B , Freund-Levi Y
Ref : J Alzheimers Dis , 57 :387 , 2017
Abstract : Bloniecki_2017_J.Alzheimers.Dis_57_387
ESTHER : Bloniecki_2017_J.Alzheimers.Dis_57_387
PubMedSearch : Bloniecki_2017_J.Alzheimers.Dis_57_387
PubMedID: 28269767

Title : Reduced cerebrospinal fluid concentration of interleukin-12\/23 subunit p40 in patients with cognitive impairment - Johansson_2017_PLoS.One_12_e0176760
Author(s) : Johansson P , Almqvist EG , Wallin A , Johansson JO , Andreasson U , Blennow K , Zetterberg H , Svensson J
Ref : PLoS ONE , 12 :e0176760 , 2017
Abstract : Johansson_2017_PLoS.One_12_e0176760
ESTHER : Johansson_2017_PLoS.One_12_e0176760
PubMedSearch : Johansson_2017_PLoS.One_12_e0176760
PubMedID: 28464009

Title : Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device - Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
Author(s) : Eyjolfsdottir H , Eriksdotter M , Linderoth B , Lind G , Juliusson B , Kusk P , Almkvist O , Andreasen N , Blennow K , Ferreira D , Westman E , Nennesmo I , Karami A , Darreh-Shori T , Kadir A , Nordberg A , Sundstrom E , Wahlund LO , Wall A , Wiberg M , Winblad B , Seiger A , Wahlberg L , Almqvist P
Ref : Alzheimers Res Ther , 8 :30 , 2016
Abstract : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
ESTHER : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
PubMedSearch : Eyjolfsdottir_2016_Alzheimers.Res.Ther_8_30
PubMedID: 27389402

Title : Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor - Ferreira_2015_J.Alzheimers.Dis_43_1059
Author(s) : Ferreira D , Westman E , Eyjolfsdottir H , Almqvist P , Lind G , Linderoth B , Seiger A , Blennow K , Karami A , Darreh-Shori T , Wiberg M , Simmons A , Wahlund LO , Wahlberg L , Eriksdotter M
Ref : J Alzheimers Dis , 43 :1059 , 2015
Abstract : Ferreira_2015_J.Alzheimers.Dis_43_1059
ESTHER : Ferreira_2015_J.Alzheimers.Dis_43_1059
PubMedSearch : Ferreira_2015_J.Alzheimers.Dis_43_1059
PubMedID: 25147108

Title : Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease - Karami_2015_Alzheimers.Dement_11_1316
Author(s) : Karami A , Eyjolfsdottir H , Vijayaraghavan S , Lind G , Almqvist P , Kadir A , Linderoth B , Andreasen N , Blennow K , Wall A , Westman E , Ferreira D , Kristoffersen Wiberg M , Wahlund LO , Seiger A , Nordberg A , Wahlberg L , Darreh-Shori T , Eriksdotter M
Ref : Alzheimers Dement , 11 :1316 , 2015
Abstract : Karami_2015_Alzheimers.Dement_11_1316
ESTHER : Karami_2015_Alzheimers.Dement_11_1316
PubMedSearch : Karami_2015_Alzheimers.Dement_11_1316
PubMedID: 25676388

Title : Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application - Wattmo_2013_Alzheimers.Res.Ther_5_2
Author(s) : Wattmo C , Jedenius E , Blennow K , Wallin AK
Ref : Alzheimers Res Ther , 5 :2 , 2013
Abstract : Wattmo_2013_Alzheimers.Res.Ther_5_2
ESTHER : Wattmo_2013_Alzheimers.Res.Ther_5_2
PubMedSearch : Wattmo_2013_Alzheimers.Res.Ther_5_2
PubMedID: 23286718

Title : Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease - Johansson_2013_PLoS.One_8_e81989
Author(s) : Johansson P , Almqvist EG , Johansson JO , Mattsson N , Andreasson U , Hansson O , Wallin A , Blennow K , Zetterberg H , Svensson J
Ref : PLoS ONE , 8 :e81989 , 2013
Abstract : Johansson_2013_PLoS.One_8_e81989
ESTHER : Johansson_2013_PLoS.One_8_e81989
PubMedSearch : Johansson_2013_PLoS.One_8_e81989
PubMedID: 24312390

Title : CSF Presenilin-1 complexes are increased in Alzheimer's disease - Garcia-Ayllon_2013_Acta.Neuropathol.Commun_1_46
Author(s) : Garcia-Ayllon MS , Campanari ML , Brinkmalm G , Rabano A , Alom J , Saura CA , Andreasen N , Blennow K , Saez-Valero J
Ref : Acta Neuropathologica Commun , 1 :46 , 2013
Abstract : Garcia-Ayllon_2013_Acta.Neuropathol.Commun_1_46
ESTHER : Garcia-Ayllon_2013_Acta.Neuropathol.Commun_1_46
PubMedSearch : Garcia-Ayllon_2013_Acta.Neuropathol.Commun_1_46
PubMedID: 24252417

Title : Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease - Hoglund_2012_J.Alzheimers.Dis_32_939
Author(s) : Hoglund K , Bogstedt A , Fabre S , Aziz A , Annas P , Basun H , Minthon L , Lannfelt L , Blennow K , Andreasen N
Ref : J Alzheimers Dis , 32 :939 , 2012
Abstract : Hoglund_2012_J.Alzheimers.Dis_32_939
ESTHER : Hoglund_2012_J.Alzheimers.Dis_32_939
PubMedSearch : Hoglund_2012_J.Alzheimers.Dis_32_939
PubMedID: 22936008

Title : Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo - Darreh-Shori_2011_Neurobiol.Aging_32_2320 e15
Author(s) : Darreh-Shori T , Forsberg A , Modiri N , Andreasen N , Blennow K , Kamil C , Ahmed H , Almkvist O , Langstrom B , Nordberg A
Ref : Neurobiology of Aging , 32 :2320 e15 , 2011
Abstract : Darreh-Shori_2011_Neurobiol.Aging_32_2320 e15
ESTHER : Darreh-Shori_2011_Neurobiol.Aging_32_2320 e15
PubMedSearch : Darreh-Shori_2011_Neurobiol.Aging_32_2320 e15
PubMedID: 20538374

Title : The apolipoprotein E epsilon4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase - Darreh-Shori_2011_Neurobiol.Aging_32_1236
Author(s) : Darreh-Shori T , Modiri N , Blennow K , Baza S , Kamil C , Ahmed H , Andreasen N , Nordberg A
Ref : Neurobiology of Aging , 32 :1236 , 2011
Abstract : Darreh-Shori_2011_Neurobiol.Aging_32_1236
ESTHER : Darreh-Shori_2011_Neurobiol.Aging_32_1236
PubMedSearch : Darreh-Shori_2011_Neurobiol.Aging_32_1236
PubMedID: 19713000

Title : Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease - Parnetti_2011_Acta.Neurol.Scand_124_122
Author(s) : Parnetti L , Chiasserini D , Andreasson U , Ohlson M , Huls C , Zetterberg H , Minthon L , Wallin AK , Andreasen N , Talesa VN , Blennow K
Ref : Acta Neurologica Scandinavica , 124 :122 , 2011
Abstract : Parnetti_2011_Acta.Neurol.Scand_124_122
ESTHER : Parnetti_2011_Acta.Neurol.Scand_124_122
PubMedSearch : Parnetti_2011_Acta.Neurol.Scand_124_122
PubMedID: 20880294

Title : The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease - Wiig_2010_Acta.Neurol.Scand_121_186
Author(s) : Wiig EH , Annas P , Basun H , Andreasen N , Lannfelt L , Zetterberg H , Blennow K , Minthon L
Ref : Acta Neurologica Scandinavica , 121 :186 , 2010
Abstract : Wiig_2010_Acta.Neurol.Scand_121_186
ESTHER : Wiig_2010_Acta.Neurol.Scand_121_186
PubMedSearch : Wiig_2010_Acta.Neurol.Scand_121_186
PubMedID: 19785641

Title : Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease - Wesnes_2010_Acta.Neurol.Scand_122_270
Author(s) : Wesnes K , Edgar C , Andreasen N , Annas P , Basun H , Lannfelt L , Zetterberg H , Blennow K , Minthon L
Ref : Acta Neurologica Scandinavica , 122 :270 , 2010
Abstract : Wesnes_2010_Acta.Neurol.Scand_122_270
ESTHER : Wesnes_2010_Acta.Neurol.Scand_122_270
PubMedSearch : Wesnes_2010_Acta.Neurol.Scand_122_270
PubMedID: 20047570

Title : CSF biomarkers predict a more malignant outcome in Alzheimer disease - Wallin_2010_Neurology_74_1531
Author(s) : Wallin AK , Blennow K , Zetterberg H , Londos E , Minthon L , Hansson O
Ref : Neurology , 74 :1531 , 2010
Abstract : Wallin_2010_Neurology_74_1531
ESTHER : Wallin_2010_Neurology_74_1531
PubMedSearch : Wallin_2010_Neurology_74_1531
PubMedID: 20458070

Title : Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study - Degerman_2010_Dement.Geriatr.Cogn.Disord_29_204
Author(s) : Degerman Gunnarsson M , Lindau M , Wall A , Blennow K , Darreh-Shori T , Basu S , Nordberg A , Larsson A , Lannfelt L , Basun H , Kilander L
Ref : Dementia & Geriatric Cognitive Disorders , 29 :204 , 2010
Abstract : Degerman_2010_Dement.Geriatr.Cogn.Disord_29_204
ESTHER : Degerman_2010_Dement.Geriatr.Cogn.Disord_29_204
PubMedSearch : Degerman_2010_Dement.Geriatr.Cogn.Disord_29_204
PubMedID: 20332638

Title : Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease? - Wallin_2009_Int.J.Geriatr.Psychiatry_24_638
Author(s) : Wallin AK , Hansson O , Blennow K , Londos E , Minthon L
Ref : Int J Geriatr Psychiatry , 24 :638 , 2009
Abstract : Wallin_2009_Int.J.Geriatr.Psychiatry_24_638
ESTHER : Wallin_2009_Int.J.Geriatr.Psychiatry_24_638
PubMedSearch : Wallin_2009_Int.J.Geriatr.Psychiatry_24_638
PubMedID: 19123199

Title : Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial - Lannfelt_2008_Lancet.Neurol_7_779
Author(s) : Lannfelt L , Blennow K , Zetterberg H , Batsman S , Ames D , Harrison J , Masters CL , Targum S , Bush AI , Murdoch R , Wilson J , Ritchie CW
Ref : Lancet Neurol , 7 :779 , 2008
Abstract : Lannfelt_2008_Lancet.Neurol_7_779
ESTHER : Lannfelt_2008_Lancet.Neurol_7_779
PubMedSearch : Lannfelt_2008_Lancet.Neurol_7_779
PubMedID: 18672400

Title : Longitudinal stability of CSF biomarkers in Alzheimer's disease - Blennow_2007_Neurosci.Lett_419_18
Author(s) : Blennow K , Zetterberg H , Minthon L , Lannfelt L , Strid S , Annas P , Basun H , Andreasen N
Ref : Neuroscience Letters , 419 :18 , 2007
Abstract : Blennow_2007_Neurosci.Lett_419_18
ESTHER : Blennow_2007_Neurosci.Lett_419_18
PubMedSearch : Blennow_2007_Neurosci.Lett_419_18
PubMedID: 17482358

Title : Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease - Garcia-Ayllon_2007_J.Neurochem_101_1701
Author(s) : Garcia-Ayllon MS , Silveyra MX , Andreasen N , Brimijoin S , Blennow K , Saez-Valero J
Ref : Journal of Neurochemistry , 101 :1701 , 2007
Abstract : Garcia-Ayllon_2007_J.Neurochem_101_1701
ESTHER : Garcia-Ayllon_2007_J.Neurochem_101_1701
PubMedSearch : Garcia-Ayllon_2007_J.Neurochem_101_1701
PubMedID: 17326766

Title : Alzheimer's disease - Blennow_2006_Lancet_368_387
Author(s) : Blennow K , de Leon MJ , Zetterberg H
Ref : Lancet , 368 :387 , 2006
Abstract : Blennow_2006_Lancet_368_387
ESTHER : Blennow_2006_Lancet_368_387
PubMedSearch : Blennow_2006_Lancet_368_387
PubMedID: 16876668

Title : Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid(1-42) (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients - Stefanova_2003_Neurosci.Lett_338_159
Author(s) : Stefanova E , Blennow K , Almkvist O , Hellstrom-Lindahl E , Nordberg A
Ref : Neuroscience Letters , 338 :159 , 2003
Abstract : Stefanova_2003_Neurosci.Lett_338_159
ESTHER : Stefanova_2003_Neurosci.Lett_338_159
PubMedSearch : Stefanova_2003_Neurosci.Lett_338_159
PubMedID: 12566177

Title : Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease - Saez-Valero_2003_J.Neurosci.Res_72_520
Author(s) : Saez-Valero J , Fodero LR , Sjogren M , Andreasen N , Amici S , Gallai V , Vanderstichele H , Vanmechelen E , Parnetti L , Blennow K , Small DH
Ref : Journal of Neuroscience Research , 72 :520 , 2003
Abstract : Saez-Valero_2003_J.Neurosci.Res_72_520
ESTHER : Saez-Valero_2003_J.Neurosci.Res_72_520
PubMedSearch : Saez-Valero_2003_J.Neurosci.Res_72_520
PubMedID: 12704813

Title : CSF markers for incipient Alzheimer's disease - Blennow_2003_Lancet.Neurol_2_605
Author(s) : Blennow K , Hampel H
Ref : Lancet Neurol , 2 :605 , 2003
Abstract : Blennow_2003_Lancet.Neurol_2_605
ESTHER : Blennow_2003_Lancet.Neurol_2_605
PubMedSearch : Blennow_2003_Lancet.Neurol_2_605
PubMedID: 14505582

Title : Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia - Wallin_2003_Dement.Geriatr.Cogn.Disord_16_200
Author(s) : Wallin A , Sjogren M , Blennow K , Davidsson P
Ref : Dementia & Geriatric Cognitive Disorders , 16 :200 , 2003
Abstract : Wallin_2003_Dement.Geriatr.Cogn.Disord_16_200
ESTHER : Wallin_2003_Dement.Geriatr.Cogn.Disord_16_200
PubMedSearch : Wallin_2003_Dement.Geriatr.Cogn.Disord_16_200
PubMedID: 14512714

Title : Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors - Parnetti_2002_Neurol.Sci_23_S95
Author(s) : Parnetti L , Amici S , Lanari A , Romani C , Antognelli C , Andreasen N , Minthon L , Davidsson P , Pottel H , Blennow K , Gallai V
Ref : Neurol Sci , 23 :S95 , 2002
Abstract : Parnetti_2002_Neurol.Sci_23_S95
ESTHER : Parnetti_2002_Neurol.Sci_23_S95
PubMedSearch : Parnetti_2002_Neurol.Sci_23_S95
PubMedID: 12548360

Title : Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease - Prince_2001_Eur.J.Hum.Genet_9_437
Author(s) : Prince JA , Feuk L , Sawyer SL , Gottfries J , Ricksten A , Nagga K , Bogdanovic N , Blennow K , Brookes AJ
Ref : Eur J Hum Genet , 9 :437 , 2001
Abstract : Prince_2001_Eur.J.Hum.Genet_9_437
ESTHER : Prince_2001_Eur.J.Hum.Genet_9_437
PubMedSearch : Prince_2001_Eur.J.Hum.Genet_9_437
PubMedID: 11436125

Title : Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease - Davidsson_2001_Neurosci.Lett_300_157
Author(s) : Davidsson P , Blennow K , Andreasen N , Eriksson B , Minthon L , Hesse C
Ref : Neuroscience Letters , 300 :157 , 2001
Abstract : Davidsson_2001_Neurosci.Lett_300_157
ESTHER : Davidsson_2001_Neurosci.Lett_300_157
PubMedSearch : Davidsson_2001_Neurosci.Lett_300_157
PubMedID: 11226635